I was replying to Whichway4$ about Morningstar valuations being useless, and in my opinion Bell Potter's valuations are more useless, giving one example of Elixinol (EXL - take a look for yourself at their 5Y chart). Whether I acted on it or not is irrelevant. EXL is also not the only example of their poor valuations, it just happens to be one I had personal experience with. I also didn't "blindly buy" based on a broker review, but they influenced me, as I'm sure you were influenced to buy A2M.
Ann: Ceasing to be a substantial holder, page-10
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.77 |
Change
0.190(2.89%) |
Mkt cap ! $4.894B | |||
| Open | High | Low | Value | Volume |
| $6.64 | $6.80 | $6.62 | $8.993M | 1.334M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5191 | $6.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.82 | 2584 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| A2M (ASX) Chart |